# Enliven Therapeutics, Inc.: insider transactions

ELVN · Nasdaq · CIK 1672619 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/elvn.md) · [Financials](/companies/elvn/financials.md) · [Filings](/companies/elvn/filings.md) · [Insiders](/companies/elvn/insiders.md)

## All transactions: 4

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2020-03-16 | [Pfizer Inc](/insiders/78003.md) | 10% owner | Purchase (P) | 312,500 | $16.00 | $5.0m | [Form 4](/filings/0000078003-20-000023.md) |
| 2020-03-16 | [Pfizer Inc](/insiders/78003.md) | 10% owner | Conversion (C) | 300,752 | not reported | not reported | [Form 4](/filings/0000078003-20-000023.md) |
| 2020-03-16 | [Pfizer Inc](/insiders/78003.md) | 10% owner | Conversion (C) | 868,467 | not reported | not reported | [Form 4](/filings/0000078003-20-000023.md) |
| 2020-03-16 | [Pfizer Inc](/insiders/78003.md) | 10% owner | Conversion (C) | 76,003 | not reported | not reported | [Form 4](/filings/0000078003-20-000023.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.